269 related articles for article (PubMed ID: 31977037)
21. Polymorphic lymphoproliferative disorder arising in a rheumatoid arthritis patient, presenting as fibrin-associated large B-cell lymphoma-like lesions in aortic and mitral valves.
Tsujii H; Nakayama R; Funakoshi S; Tsuji S; Haga H; Ono K
Pathol Int; 2024 May; 74(5):285-291. PubMed ID: 38563592
[TBL] [Abstract][Full Text] [Related]
22. Methotrexate-related lymphoproliferative disorder of the stomach in a patient with rheumatoid arthritis: a case of disease regression after methotrexate cessation.
Ikeda K; Nakamura T; Kinoshita T; Fujiwara M; Uose S; Someda H; Miyoshi T; Io K; Nagai K
Clin J Gastroenterol; 2016 Feb; 9(1):17-21. PubMed ID: 26733461
[TBL] [Abstract][Full Text] [Related]
23. Methotrexate-associated lymphoproliferative disorder in the stomach and duodenum: a case report.
Toyonaga H; Fukushima M; Shimeno N; Inokuma T
BMC Gastroenterol; 2019 Apr; 19(1):62. PubMed ID: 31023238
[TBL] [Abstract][Full Text] [Related]
24. Enhanced PD-L1 expression on tumor cells in primary cutaneous large T-cell lymphoma with CD30 expression as classic Hodgkin lymphoma mimics: A report of lymph node lesions of two cases.
Takahashi E; Tsuchida T; Baba S; Tsuzuki T; Shimauchi T; Tokura Y; Tamada Y; Nakamura S
Pathol Int; 2020 Oct; 70(10):804-811. PubMed ID: 32783303
[TBL] [Abstract][Full Text] [Related]
25. Clinicopathological features of clinical methotrexate-related lymphoproliferative disorders.
Tokuhira M; Saito S; Suzuki K; Higashi M; Momose S; Shimizu T; Mori T; Kimura Y; Amano K; Okamoto S; Takeuchi T; Tamaru JI; Kizaki M
Leuk Lymphoma; 2019 Oct; 60(10):2508-2515. PubMed ID: 30947579
[TBL] [Abstract][Full Text] [Related]
26. The clinical impact of absolute lymphocyte count in peripheral blood among patients with methotrexate - associated lymphoproliferative disorders.
Tokuhira M; Tanaka Y; Takahashi Y; Kimura Y; Tomikawa T; Anan T; Watanabe J; Sagawa M; Higashi M; Momose S; Amano K; Tabayashi T; Nakaseko R; Tamaru JI; Kizaki M
J Clin Exp Hematop; 2020 Jun; 60(2):41-50. PubMed ID: 32404570
[TBL] [Abstract][Full Text] [Related]
27. Methotrexate-associated lymphoproliferative disorders mimicking angioimmunoblastic T-cell lymphoma.
Hatanaka K; Nakamura N; Kojima M; Ando K; Irie S; Bunno M; Nakamine H; Uekusa T
Pathol Res Pract; 2010 Jan; 206(1):9-13. PubMed ID: 19628340
[TBL] [Abstract][Full Text] [Related]
28. A clinical, pathological, and genetic characterization of methotrexate-associated lymphoproliferative disorders.
Yamakawa N; Fujimoto M; Kawabata D; Terao C; Nishikori M; Nakashima R; Imura Y; Yukawa N; Yoshifuji H; Ohmura K; Fujii T; Kitano T; Kondo T; Yurugi K; Miura Y; Maekawa T; Saji H; Takaori-Kondo A; Matsuda F; Haga H; Mimori T
J Rheumatol; 2014 Feb; 41(2):293-9. PubMed ID: 24334644
[TBL] [Abstract][Full Text] [Related]
29. Epstein-Barr virus infection and gene promoter hypermethylation in rheumatoid arthritis patients with methotrexate-associated B cell lymphoproliferative disorders.
Ejima-Yamada K; Oshiro Y; Okamura S; Fujisaki T; Mihashi Y; Tamura K; Fukushige T; Kojima M; Shibuya K; Takeshita M
Virchows Arch; 2017 Feb; 470(2):205-215. PubMed ID: 27864689
[TBL] [Abstract][Full Text] [Related]
30. Reversible methotrexate-associated lymphoproliferative disorder resembling advanced gastric cancer in a patient with rheumatoid arthritis.
Satoh K; Yoshida N; Imaizumi K; Yajima M; Wakui H; Sawada K; Komatsuda A
Am J Med Sci; 2009 Oct; 338(4):334-5. PubMed ID: 19745701
[TBL] [Abstract][Full Text] [Related]
31. Clinicopathological evaluation of the programmed cell death 1 (PD1)/programmed cell death-ligand 1 (PD-L1) axis in post-transplant lymphoproliferative disorders: association with Epstein-Barr virus, PD-L1 copy number alterations, and outcome.
Veloza L; Teixido C; Castrejon N; Climent F; Carrió A; Marginet M; Soldini D; González-Farré B; Ribera-Cortada I; Lopez-Guillermo A; González-Barca E; Sierra A; Herrera M; Gómez C; Garcia A; Balagué O; Campo E; Martinez A
Histopathology; 2019 Dec; 75(6):799-812. PubMed ID: 30861172
[TBL] [Abstract][Full Text] [Related]
32. Clinical aspects in patients with rheumatoid arthritis complicated with lymphoproliferative disorders without regression after methotrexate withdrawal and treatment for arthritis after regression of lymphoproliferative disorders.
Nakano K; Saito K; Nawata A; Hanami K; Kubo S; Miyagawa I; Fujino Y; Nakayamada S; Tanaka Y
Mod Rheumatol; 2021 Jan; 31(1):94-100. PubMed ID: 32159414
[TBL] [Abstract][Full Text] [Related]
33. Spontaneous regression of lymphoproliferative disorders in patients treated with methotrexate for rheumatoid arthritis and other rheumatic diseases.
Salloum E; Cooper DL; Howe G; Lacy J; Tallini G; Crouch J; Schultz M; Murren J
J Clin Oncol; 1996 Jun; 14(6):1943-9. PubMed ID: 8656264
[TBL] [Abstract][Full Text] [Related]
34. Methotrexate-associated Lymphoproliferative Disorder: A Rare Differential Diagnosis of Wheezes.
Ujino M; Miyoshi S; Sugimoto N; Arai H; Ota Y; Sasajima Y; Kawamura M; Nagase H; Yamaguchi M; Ohta K
Intern Med; 2019 Jun; 58(12):1759-1764. PubMed ID: 30713294
[TBL] [Abstract][Full Text] [Related]
35. Distinct patterns of lymphocyte count transition in lymphoproliferative disorder in patients with rheumatoid arthritis treated with methotrexate.
Saito S; Kaneko Y; Yamaoka K; Tokuhira M; Takeuchi T
Rheumatology (Oxford); 2017 Jun; 56(6):940-946. PubMed ID: 28165538
[TBL] [Abstract][Full Text] [Related]
36. Diagnostic utility of programmed cell death ligand 1 (clone SP142) in mediastinal composite lymphoma: A report of two cases.
Sakakibara A; Kohno K; Iwakoshi A; Moritani S; Fujishiro A; Kito K; Suzuki Y; Shimada S; Nakaguro M; Shimoyama Y; Takahara T; Takahashi E; Ohashi A; Satou A; Kato S; Asano N; Nakamura S
Pathol Int; 2020 Feb; 70(2):116-122. PubMed ID: 31894883
[TBL] [Abstract][Full Text] [Related]
37. Methotrexate-associated lymphoproliferative disorders of the tongue developing in patients with rheumatoid arthritis: a report of 2 cases and a review.
Hashimoto K; Nagao T; Saito T; Kinoshita H
Oral Surg Oral Med Oral Pathol Oral Radiol; 2015 Jan; 119(1):e1-5. PubMed ID: 24927637
[TBL] [Abstract][Full Text] [Related]
38. Methotrexate-associated lymphoproliferative disorder with an osteolytic vertebral lesion in an elderly patient with rheumatoid arthritis: A case report.
Hirata C; Kenzaka T; Akita H
J Clin Pharm Ther; 2021 Aug; 46(4):1178-1181. PubMed ID: 33768586
[TBL] [Abstract][Full Text] [Related]
39. Clinical management for other iatrogenic immunodeficiency-associated lymphoproliferative disorders.
Tokuhira M; Tamaru JI; Kizaki M
J Clin Exp Hematop; 2019; 59(2):72-92. PubMed ID: 31257348
[TBL] [Abstract][Full Text] [Related]
40. [Primary central nervous system methotrexate associated lymphoproliferative disorders in a patient with rheumatoid arthritis].
Uchida Y; Hokkoku K; Hatanaka Y; Kikuchi Y; Tashiro H; Sonoo M
Rinsho Shinkeigaku; 2018 Aug; 58(8):485-491. PubMed ID: 30068810
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]